Shannon, Kevin M <br/><br/>
Resistance in the land of molecular cancer therapeutics.  [electronic resource] 

 -  Cancer cell  Aug 2002 
 - 99-102 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>1535-6108 
<br/><br/><label>Standard No.: </label>10.1016/s1535-6108(02)00101-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Benzamides<br/>Disease Progression<br/>Drug Resistance, Neoplasm--genetics<br/>Fusion Proteins, bcr-abl--chemistry<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Mutation<br/>Piperazines--administration & dosage<br/>Pyrimidines--administration & dosage